• eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
    advertisement
  • .station_logo.
    ..

    the total amount paid out in critical illness claims was £75.19m, with cancer accounting for 74 per cent of claims from women, mainly breast cancer, alongside 51 per cent from men..nato secretary general and president trump discuss preparations for july summit..

    may 17, 2018